264 related articles for article (PubMed ID: 16153266)
1. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
2. Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampin.
Ostronoff M; Ostronoff F; Sucupira A; Souto Maior AP; Caniza M; Florêncio R; Domingues MC; Calixto R; Matias K
Int J Infect Dis; 2006 Jul; 10(4):339-40. PubMed ID: 16412679
[No Abstract] [Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
4. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
Elkhouly AE; el-Sokkary MA; el-Emam MA
Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
[No Abstract] [Full Text] [Related]
5. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
6. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
[No Abstract] [Full Text] [Related]
7. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
8. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
9. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N
Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
[No Abstract] [Full Text] [Related]
11. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity in vitro to antibiotics and chemotherapeutic agents in various hospital strains of Pseudomonas aeruginosa].
Bertaggia A; De Negri M
Boll Ist Sieroter Milan; 1974; 50(1):45-53. PubMed ID: 4204863
[No Abstract] [Full Text] [Related]
13. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
15. [Effect of combination of morphocycline and levomycetin on Pseudomonas aeruginosa].
Poliak MS
Antibiotiki; 1968 Dec; 13(12):1090-5. PubMed ID: 4976186
[No Abstract] [Full Text] [Related]
16. [Trend of therapy in Pseudomonas aeruginosa infections].
Jannuzzi C; Tassara A
G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
[No Abstract] [Full Text] [Related]
17. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
[No Abstract] [Full Text] [Related]
20. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
Saiman L
Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
